Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
DURECT Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
DRRX
Nasdaq
8731
https://www.durect.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for DURECT Corp
Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates
- Mar 27th, 2024 9:10 pm
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Mar 27th, 2024 8:01 pm
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update
- Mar 20th, 2024 8:30 pm
DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada
- Mar 4th, 2024 12:00 pm
Pacira (PCRX) Matches Q4 Earnings Estimates
- Feb 29th, 2024 2:15 pm
DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 7th, 2024 11:48 pm
Q3 2023 DURECT Corp Earnings Call
- Nov 14th, 2023 1:05 pm
DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update
- Nov 13th, 2023 9:05 pm
Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for
- Nov 13th, 2023 3:00 pm
DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update
- Nov 9th, 2023 9:30 pm
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on Mortality
- Nov 7th, 2023 9:01 pm
These 2 ‘Strong Buy’ Penny Stocks Have Massive Upside Potential, Says Oppenheimer
- Oct 19th, 2023 2:44 pm
3 Promising Biotech Stocks That Will Make Early Investors Rich
- Oct 2nd, 2023 7:07 pm
DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis
- Sep 7th, 2023 11:00 am
DURECT Corporation Announces Presentations in Upcoming Investor Conferences
- Aug 31st, 2023 8:30 pm
10 Oversold Penny Stocks To Buy
- Aug 14th, 2023 11:55 am
Q2 2023 DURECT Corp Earnings Call
- Aug 10th, 2023 11:08 am
Durect (DRRX) Reports Q2 Loss, Misses Revenue Estimates
- Aug 9th, 2023 9:50 pm
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update
- Aug 9th, 2023 8:05 pm
DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business Update
- Aug 3rd, 2023 8:30 pm
Scroll